Proveris Scientific Announces Participation in the 2018 RDD Conference

Marlborough, MA, March 27, 2018 – Proveris Scientific Corporation announces its participation in RDD (Respiratory Drug Delivery), a leading conference focusing on the development and commercialization of pulmonary and nasal pharmaceutical products. This five-day event will be held 22-26 April, 2018 at JW Marriott Starr Pass Resort & Spa Tucson, Arizona.

Attendees at the conference can learn how Proveris’s OINDP testing instruments, technologies and laboratory services can help gain understanding of product performance and the interactions between devices, formulations and human usage.

In addition to being a Silver Sponsor, Proveris will have a team of experts at their stand in the Technology Exhibition area and will present research on the Impact of Actuator Design on Multi Dose Nasal Spray Characteristics in the Scientific Poster Session. Visitors to the Proveris stand will be able to see the new Kinaero™ High-Throughput Fire Down System and learn how it increases pMDI testing efficiency in Product Development and QC workflows.

The Proveris team attending the conference are Ben Okorodudu, Vice President of Sales, Christopher Mapel, Sales Director for the Americas, Heli Chauhan, Senior Applications Chemist, and Denis Bonaccolta, Product Manager. “Our Silver Sponsorship and participation at RDD underscores our dedication to the advancement of high-quality science in the global inhalation community” said Ben Okorodudu. “We are looking forward to meeting with our customers to introduce our new products, and discuss how our technologies can help reduce product development timelines, and enhance product quality.”

About Proveris Scientific:

Proveris Scientific Corporation advances the science of nasal and inhaled drug delivery by providing leading technology in spray performance measurement, unrivaled accuracy in automated actuation, and expertise in drug-device optimization. Since its founding in 1995, the company has accelerated the development the top spray drug products and has deployed its systems at more than 100 pharmaceutical development and manufacturing sites around the globe. Proveris’s systems are the industry standard and are used by the FDA, CFDA, and the pharmaceutical industry to generate submission-ready data. Proveris is certified to ISO 9001:2008 by TUV Rheinland of North America and has more than 20 patents on its technology issued in United States, Europe, and Asia. For more information, please visit www.proveris.com.